These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 12854136)
21. Effect of survivin on cell proliferation and apoptosis in gastric cancer. Wakana Y; Kasuya K; Katayanagi S; Tsuchida A; Aoki T; Koyanagi Y; Ishii H; Ebihara Y Oncol Rep; 2002; 9(6):1213-8. PubMed ID: 12375022 [TBL] [Abstract][Full Text] [Related]
22. Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A. Hino R; Uozaki H; Inoue Y; Shintani Y; Ushiku T; Sakatani T; Takada K; Fukayama M Cancer Res; 2008 Mar; 68(5):1427-35. PubMed ID: 18316606 [TBL] [Abstract][Full Text] [Related]
23. Downregulation of survivin inhibits proliferation and migration of human gastric carcinoma cells. Li Y; Zhou Y; Zheng J; Niu C; Liu B; Wang M; Fang H; Hou C Int J Clin Exp Pathol; 2015; 8(2):1731-6. PubMed ID: 25973061 [TBL] [Abstract][Full Text] [Related]
24. Expression of survivin in gastric cancer and its relationship with tumor angiogenesis. Lee GH; Joo YE; Koh YS; Chung IJ; Park YK; Lee JH; Kim HS; Choi SK; Rew JS; Park CS; Kim SJ Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):957-63. PubMed ID: 16894308 [TBL] [Abstract][Full Text] [Related]
25. [Elevated expression level of wild-type survivin in gastric cancer promotes in vitro docetaxel-resistance]. Meng H; Lu CD; Dai DJ; Sun YL; Tanigawa N Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2060-3. PubMed ID: 15730616 [TBL] [Abstract][Full Text] [Related]
26. CEACAM5 has different expression patterns in gastric non-neoplastic and neoplastic lesions and cytoplasmic staining is a marker for evaluation of tumor progression in gastric adenocarcinoma. Liu JN; Wang HB; Zhou CC; Hu SY Pathol Res Pract; 2014 Oct; 210(10):686-93. PubMed ID: 25042385 [TBL] [Abstract][Full Text] [Related]
27. O-GlcNAcylation is associated with the development and progression of gastric carcinoma. Jang TJ; Kim UJ Pathol Res Pract; 2016 Jul; 212(7):622-30. PubMed ID: 27131860 [TBL] [Abstract][Full Text] [Related]
28. Differential expression of intracellular apoptotic signaling molecules in tumor and tumor-infiltrating lymphocytes during development of invasion and/or metastasis of gastric carcinoma. Koyama S Dig Dis Sci; 2003 Dec; 48(12):2290-300. PubMed ID: 14714615 [TBL] [Abstract][Full Text] [Related]
29. KLF4 expression and apoptosis-related markers in gastric cancer. Krstic M; Stojnev S; Jovanovic L; Marjanovic G J BUON; 2013; 18(3):695-702. PubMed ID: 24065485 [TBL] [Abstract][Full Text] [Related]
30. Overexpression of βIII-tubulin and survivin associated with drug resistance to docetaxel-based chemotherapy in advanced gastric cancer. Zheng WE; Chen H; Yuan SF; Wu LL; Zhang W; Sun HY; Chen WJ J BUON; 2012; 17(2):284-90. PubMed ID: 22740207 [TBL] [Abstract][Full Text] [Related]
31. Overexpression of the p53 tumor suppressor gene product in esophageal and gastric carcinomas. Fléjou JF; Muzeau F; Potet F; Lepelletier F; Fékété F; Hénin D Pathol Res Pract; 1994 Dec; 190(12):1141-8. PubMed ID: 7540752 [TBL] [Abstract][Full Text] [Related]
32. COL4A3 expression correlates with pathogenesis, pathologic behaviors, and prognosis of gastric carcinomas. Nie XC; Wang JP; Zhu W; Xu XY; Xing YN; Yu M; Liu YP; Takano Y; Zheng HC Hum Pathol; 2013 Jan; 44(1):77-86. PubMed ID: 22939955 [TBL] [Abstract][Full Text] [Related]
33. A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins. Idenoue S; Hirohashi Y; Torigoe T; Sato Y; Tamura Y; Hariu H; Yamamoto M; Kurotaki T; Tsuruma T; Asanuma H; Kanaseki T; Ikeda H; Kashiwagi K; Okazaki M; Sasaki K; Sato T; Ohmura T; Hata F; Yamaguchi K; Hirata K; Sato N Clin Cancer Res; 2005 Feb; 11(4):1474-82. PubMed ID: 15746049 [TBL] [Abstract][Full Text] [Related]
34. [Expression of survivin gene in pancreatic carcinoma]. Liang ZY; Liu TH; Luo YF; Guan J; Wei SZ; Cao JL; Gao J; Cui QC Zhonghua Bing Li Xue Za Zhi; 2005 Feb; 34(2):67-70. PubMed ID: 15842798 [TBL] [Abstract][Full Text] [Related]
35. Immunofluorescent staining of gastric mucosal glycoprotein in gastric carcinoma of dogs and rats induced by N-methyl-N'-nitro-N-nitrosoguanidine. Kawasaki H; Nakayama K; Kimoto E Gan; 1975 Aug; 66(4):427-31. PubMed ID: 1102380 [TBL] [Abstract][Full Text] [Related]
36. Vascular endothelial growth factor and survivin immunostaining in gastric adenocarcinoma. Bury J; Szumiło J; Dąbrowski A; Ciechański A; Śliwińska J; Wallner G Pol Przegl Chir; 2012 Jul; 84(7):341-7. PubMed ID: 22935455 [TBL] [Abstract][Full Text] [Related]
37. [Prognostic significance of survivin splicing variants in expression gastric cancer]. Meng H; Dai DJ; Lu CD Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):234-6. PubMed ID: 16167236 [TBL] [Abstract][Full Text] [Related]
38. Relationship between trefoil factor 1 expression and gastric mucosa injuries and gastric cancer. Ren JL; Luo JY; Lu YP; Wang L; Shi HX World J Gastroenterol; 2005 May; 11(17):2674-7. PubMed ID: 15849833 [TBL] [Abstract][Full Text] [Related]
39. Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis. Slesak B; Harlozinska A; Porebska I; Bojarowski T; Lapinska J; Rzeszutko M; Wojnar A Anticancer Res; 1998; 18(4A):2727-32. PubMed ID: 9703936 [TBL] [Abstract][Full Text] [Related]
40. [Expression and significance of survivin in colon cancer]. Jiang ZM; Yao HR; Zhan J; Xie DR; Li HG Ai Zheng; 2004 Nov; 23(11 Suppl):1414-7. PubMed ID: 15566647 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]